HOME >> MEDICINE >> NEWS
Treatments for prostate cancer may affect employment

Prostate cancer and its treatment may affect short-term employment status, and debilitating effects from the treatment may impede some job-related tasks, reports a new study in the July 6 issue of the Journal of the National Cancer Institute.

As more organizations recommend screening younger men for prostate cancer, the profile of prostate cancer patients is likely to shift from men older than 65 years to younger men who are more likely to still be in the work force. Treatments for prostate cancer can involve a number of complications, including incontinence, fatigue, or sexual dysfunction, many of which may interfere with work productivity.

To determine the influence of cancer treatment on employment, Cathy J. Bradley, Ph.D., of the Massey Cancer Center at Virginia Commonwealth University in Richmond, and colleagues tracked 267 men with prostate cancer who were employed at the start of the study. They asked the patients about their employment situation 3 months prior to receiving their diagnosis of cancer, and at 6 and 12 months after the diagnosis. They compared the results with those from two control groups of men without prostate cancer selected from U.S. Census population surveys.

The authors found that men with prostate cancer were 10% less likely to be working 6 months after their cancer diagnosis than men without the disease. However, approximately two-thirds of the patients still working said that they continued working out of fear of losing health insurance coverage. The authors note that this fear may have encouraged some who otherwise would have quit to keep working, which may have suppressed unemployment numbers. Additionally, those still working had decreased their weekly hours work by 4 hours on average, and 43% of them attributed their inability to work at their former capacity to cancer treatment-related symptoms.

After 12 months, the gap in employment status disappeared. However, some men with can
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
5-Jul-2005


Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
3. African-American men understimate risk of prostate cancer
4. Treatment for early prostate cancer associated with type of specialist seen
5. Nonhormonal drug reduces hot flashes in men treated for prostate cancer
6. Flaxseed stunts the growth of prostate tumors
7. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
8. Radium-223: An alternative treatment for prostate cancer
9. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
10. New prostate cancer clinical guidelines to be released
11. Data on new vaccine for prostate cancer to be presented

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... established the certification process to promote standards of excellence for the field of ... scheduled for March 22 – 25, 2018 in Orlando, Florida at the Omni ...
(Date:10/13/2017)... Ill. (PRWEB) , ... October ... ... Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer ... healthcare professionals on guideline updates for the primary prevention of cardiovascular diseases ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device ... precise destruction of targeted tissues, announced three leadership team developments today:   ... Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology:
Cached News: